» Related Searches: cancer, lung cancer treatment, cancer risk, prostate cancer, cancer patients
Result 1 of 1
NICE consults on advice on two treatments for NSCLC
OnMedica Latest News — 14th Nov 2006, 10:02 GMT
The National Institute for Health and Clinical Excellence has issued appraisal
consultation documents on Tarceva (erlotinib) and Alimat (pemetrexed) for the treatment of
non-small-cell lung cancer, recommending neither drug … 